Ongoing legislative developments and the latest experiences with implementing alternative payment mechanisms are just some of the reasons Clifford Goodman, PhD, senior vice president and director at the Center for Comparative Effectiveness Research at the Lewin Group, is looking forward to the fall meeting of the ACO & Emerging Healthcare Delivery Coalition.
Ongoing legislative developments and the latest experiences with implementing alternative payment mechanisms are just some of the reasons Clifford Goodman, PhD, senior vice president and director at the Center for Comparative Effectiveness Research at the Lewin Group, is looking forward to the fall meeting of the ACO & Emerging Healthcare Delivery Coalition.
Transcript (slightly modified)
Why should someone attend the fall meeting of the ACO & Emerging Healthcare Delivery Coalition, being held October 26-27 in Nashville, Tennessee?
Thinking about the fall meeting in Nashville, I’m already looking forward to that because of a few things. One is that by then, we’re going to see a lot more of how the healthcare legislation is going to be playing out. What really will have happened to the Affordable Care Act? Will there really be a new AHCA [American Health Care Act] in place? Those contextual trends are going to be very important for understanding where we go next with the ACO Coalition. That’s a very important thing.
Also, I see a trend, or I should say kind of an ongoing continuous development, of shared learning among our people that do attend this meeting on an ongoing basis. We continue to develop, learn from, refine, and then continue to implement these different sort of models, value-based models, for really providing alternative payment mechanisms for accountable care organizations and others to better serve our patient populations.
It’s the changes in the political environment, certainly advances in sciences and the state-of-the-art, and the ongoing exchange of on-the-ground experience that will make an event like that really successful.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More